UltraTech Cement Limited appears to be a financially healthy company with strong profitability metrics, including high gross margins and EBITDA margins. The company's ROE is also decent, indicating efficient use of shareholder equity. However, the company's valuation seems stretched, with a high trailing and forward P/E ratio, suggesting that the stock may be overpriced. A weakness is the company's slow revenue and earnings growth, which may be a concern for investors. The debt-to-equity ratio is moderate, but manageable, indicating a relatively stable debt position.